کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1394192 1501138 2014 13 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase
ترجمه فارسی عنوان
طراحی، سنتز و ارزیابی بیولوژیکی جدید تریآیدروآکاردین پرییدین آلدوکسیم و آمیدوکسیم هیبریدی به عنوان کارآمد واکنشگرهای خاموش کننده عامل عصبی - مهارکننده استیل کولین استراز
کلمات کلیدی
عوامل عصبی بنزن ارگانوفسفره، واکنش استیل کولین استراز، پرییدین دیالکسیم، اکسیم هیبرید، تاکرین
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آلی
چکیده انگلیسی


• We design and synthesize novel uncharged bifunctional reactivators hybrids for the reactivation of phosphylated-human acetylcholinesterase.
• These molecules exhibit higher reactivation characteristics in comparison to known and currently approved antidotes.
• The new compounds exhibit broader reactivity spectrum as well.

A series of new uncharged functional acetylcholinesterase (AChE) reactivators including heterodimers of tetrahydroacridine with 3-hydroxy-2-pyridine aldoximes and amidoximes has been synthesized. These novel molecules display in vitro reactivation potencies towards VX-, tabun- and paraoxon-inhibited human AChE that are superior to those of the mono- and bis-pyridinium aldoximes currently used against nerve agent and pesticide poisoning. Furthermore, these uncharged compounds exhibit a broader reactivity spectrum compared to currently approved remediation drugs.

Broad spectrum efficacy of uncharged hybrid reactivators: The rational design and synthesis of novel functional tacrine based reactivators heterodimers allowed to reactivate efficiently VX, tabun and paraoxon inhibited human acetylcholine esterase in vitro.Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Medicinal Chemistry - Volume 78, 6 May 2014, Pages 455–467
نویسندگان
, , , , , , , , , , , , ,